Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Emily L. Ryon"'
Autor:
Joshua P. Kronenfeld, Jessica S. Crystal, Emily L. Ryon, Sina Yadegarynia, Celeste Chitters, Raphael Yechieli, Gina D’Amato, Andrew E. Rosenberg, Susan B. Kesmodel, Jonathan C. Trent, Neha Goel
Publikováno v:
Cancers, Vol 13, Iss 15, p 3814 (2021)
Background: The optimal management of primary angiosarcoma (PAS) and radiation-associated angiosarcoma (RAAS) of the breast remains undefined. Available data show persistently poor survival outcomes following treatment with surgery or chemotherapy al
Externí odkaz:
https://doaj.org/article/927fe967d1ff4e04b9128901e2733ab0
Publikováno v:
Journal of Vascular Surgery: Venous and Lymphatic Disorders. 10:233-240
Great saphenous vein (GSV) antireflux procedures have evolved during the past few decades to reduce elevated venous pressure. Untreated reflux in the below knee (BK) GSV (BK-GSV) can lead to persistent venous hypertension and deterioration of the ven
Autor:
Emily L. Ryon, Sommer Luu, Joshua P. Kronenfeld, Annie Wang, Maria C. Russell, Neha Goel, Adam C. Yopp, Ann Y. Lee, David S. Goldberg, Eric J. Silberfein, Nipun B. Merchant, Rachel M. Lee, Cary Hsu
Publikováno v:
HPB (Oxford)
BACKGROUND: Access to health insurance and curative interventions [surgery/liver directed therapy (LDT)] affects survival for early-stage hepatocellular carcinoma (HCC). The aim of this multi-institutional study of high-volume safety-net hospitals (S
Autor:
Alex Lall, Emily L. Ryon, Jorge Rey, Hilene DeAmorim, John K. Karwowski, Arash Bornak, Stefan Kenel-Pierre, Naixin Kang, Joshua P. Kronenfeld
Publikováno v:
Vascular
Objectives To report our experience and compare the results of percutaneous endovascular aortic aneurysm repair (PEVAR) performed under monitored anesthesia care (MAC) to PEVAR under general anesthesia (GA). Methods A retrospective review of patients
Autor:
Shishir K. Maithel, Eric J. Silberfein, Cary Hsu, Maria C. Russell, Emily L. Ryon, Annie Wang, Rachel M. Lee, Sommer Luu, Michael K. Turgeon, Neha Goel, Adam C. Yopp, Adriana C. Gamboa, Ann Y. Lee
Publikováno v:
HPB (Oxford)
BACKGROUND: Widespread HCV treatment for hepatocellular carcinoma (HCC) patients remains limited. Our aim was to evaluate the association of HCV treatment with survival and assess barriers to treatment. METHODS: Patients in the U.S. Safety Net Collab
Autor:
Emily L. Ryon, Nipun B. Merchant, Ahkeel Allen, Mecker G. Möller, Erin Kobetz, Dido Franceschi, Kristin N. Kelly, Susan B. Kesmodel, Eli Avisar, Neha Goel
Publikováno v:
Breast Cancer Research and Treatment. 187:197-206
Public safety net hospitals (SNH) serve a disparate patient population; however, little is known about long-term oncologic outcomes of patients receiving care at these facilities. This study is the first to examine overall survival (OS) and the initi
Autor:
Eduardo A. Perez, Hallie J. Quiroz, Juan E. Sola, Emily L. Ryon, Samantha F. Valencia, Chad M. Thorson, Brent A. Willobee, Anthony Ferrantella
Publikováno v:
Journal of Pediatric Surgery. 56:61-65
This study aims to determine postoperative outcomes and readmissions in pediatric cholecystectomy with routine intraoperative cholangiogram (IOC) utilization.The Nationwide Readmissions Database 2010-2014 was queried for all pediatric cholecystectomi
Autor:
Brent A. Willobee, Carlos T. Huerta, Hallie J. Quiroz, Melissa L. Mao, Emily L. Ryon, Anthony Ferrantella, Chad M. Thorson, Juan E. Sola, Eduardo A. Perez
Publikováno v:
The Journal of surgical research. 283
This study aims to analyze the relative risks for total thyroidectomies by comparing complication rates for total versus partial thyroidectomy in the pediatric population.We queried the Kids' Inpatient Database (KID) 1997-2012 for all cases of total
Autor:
Joshua P. Kronenfeld, Sommer Luu, Michael K. Turgeon, Adriana C. Gamboa, Cary Hsu, Annie Wang, Adam C. Yopp, Emily L. Ryon, Ann Y. Lee, Maria C. Russell, Eric J. Silberfein, Neha Goel, Shishir K. Maithel, Rachel M. Lee
Publikováno v:
Am Surg
Background Hepatitis C virus (HCV) has historically been the most common cause of cirrhosis and hepatocellular carcinoma (HCC) in the United States. With improved HCV treatment, cirrhosis secondary to other etiologies is increasing. Given this changi
Autor:
Robert C.G. Martin, Sharon M. Weber, Vikas Dudeja, Patrick B. Schwartz, David A. Kooby, Ryan C. Fields, Hong J. Kim, Charles R. Scoggins, Rachel M. Lee, Ugwuji N. Maduekwe, Emily L. Ryon, Daniel E. Abbott, Syed A. Ahmad, William G. Hawkins, Shishir K. Maithel, Nipun B. Merchant, Sameer H. Patel, Dido Franceschi, Greg Williams, Alan S. Livingstone, Francis Igor Macedo
Publikováno v:
Ann Surg
OBJECTIVE: To compare the survival outcomes associated with clinical and pathological response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant chemotherapy (NAC) with FOLFIRINOX (FLX) or gemcitabine/nab-paclitaxel (GNP) foll